Get a reply from this employer
Your resume and cover letter, tailored to exactly what they’re hiring for.
GlaxoSmithKline plc is seeking an experienced OT Security Architect to own and evolve security architecture across manufacturing, labs, and research, including IEC 62443 zone/conduit design and Purdue model segmentation. You will lead a global team of OT architects and coordinate with Cyber Defence and vendors within GxP constraints.
Ideal candidates bring 20+ years in OT security architecture, direct experience with OT monitoring platforms, and a track record of delivering secure, compliant OT
Own OT Security architecture across GSK's global manufacturing, laboratory and research estate, leading a team of seven.
You own IEC 62443 zone and conduit design, Purdue model segmentation, safety system boundaries, OT vulnerability and detection architecture, and the convergence of IT and OT security controls in a GxP-validated environment.
Security Architecture and Solution Engineering sets the target-state security architecture for GSK and builds the solutions that realise it. The function brings IT and OT architecture under single ownership for the first time, spanning Network and Zero Trust, Application Security, Platform Security, MDR and Detection Engineering, VM and Configuration Management, Data Security, and OT Security across a global manufacturing, laboratory and research estate. Architecture sets the standards and reference designs, Solution Engineering builds, tests and packages them, and a managed service vendor operates them. Architecture accountability never transfers: Cyber Architecture and Solutions designs and builds, the vendor runs. Twenty roles, with standards applying in more than 100 countries.
What makes this role different. OT security in pharmaceutical manufacturing is not IT security applied to different hardware. A control that is routine in IT can halt a production line or invalidate a GxP validation, and change design has to account for that from the start. You will need genuine IEC 62443 and Purdue model depth — IT security leadership alone does not transfer, and the interview will test this directly.
20+ years in security architecture, including managing matrixed reports across geographies — domain focus: OT Security (OT,ICS and IoT across manufacturing, laboratory and research sites); domain authority aligned to IEC62443 and the Purdue Model OT network zone and conduit segmentation and OT monitoring integration using Claroty, Dragos or Nozomi Networks OT vulnerability management where IT patching cannot be applied — compensating controls, automated asset discovery and risk posture reporting — and OT detection patterns and playbooks for the SOC and vendor Leading an OT specialist team within GxP-validated manufacturing constraints, where a routine IT control can halt production ApplyingAI andML to OT security — anomaly detection in OT networks, AI-assisted asset discovery and secure adoption of AI in manufacturing.
Leading an OT transformation or Future Ready OT style programme at enterprise scale OT asset discovery architecture across sites with incomplete or unreliable inventories NIS2 scoping and reporting obligations for manufacturing sites in scope, and the evidence a competent authority expects. OT risk posture reporting to executive leadership, including automated dashboards, and direct engagement with site engineering and operations teams Partnering with Cyber Defence on OT threat exposure management and OT SOC handoffs.
• Bachelor's degree in a relevant discipline, or equivalent professional experience.
Typical tools and technologies: IEC62443 zone and conduit design, Purdue model segmentation, OT monitoring platforms including Claroty, Dragos and Nozomi Networks, unidirectional gateways and data diodes,ICS,SCADA andPLC security patterns, OT asset discovery, safety instrumented system boundaries, OT vulnerability management and compensating controls, GxP-validated change control.
Uniting science, technology and talent to get ahead of disease together. GSK is a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of the decade, as a successful, growing company where people can thrive. We get ahead of disease by preventing and treating it with innovation in specialty medicines and vaccines. We focus on four therapeutic areas: respiratory, immunology and inflammation; oncology; HIV; and infectious diseases – to impact health at scale. People and patients around the world count on the medicines and vaccines we make, so we’re committed to creating an environment where our people can thrive and focus on what matters most. Our culture of being ambitious for patients, accountable for impact and doing the right thing is the foundation for how, together, we deliver for patients, shareholders and our people.
Inclusion at GSK: As an employer committed to Inclusion, we encourage you to reach out if you need any adjustments during the recruitment process. Please contact our Recruitment Team at IN.recruitment-adjustments@gsk.com to discuss your needs.
GSK does not accept referrals from employment businesses and/or employment agencies in respect of the vacancies posted on this site. All employment businesses/agencies are required to contact GSK's commercial and general procurement/human resources department to obtain prior written authorization before referring any candidates to GSK. The obtaining of prior written authorization is a condition precedent to any agreement (verbal or written) between the employment business/ agency and GSK. In the absence of such written authorization being obtained any actions undertaken by the employment business/agency shall be deemed to have been performed without the consent or contractual agreement of GSK. GSK shall therefore not be liable for any fees arising from such actions or any fees arising from any referrals by employment businesses/agencies in respect of the vacancies posted on this site.
We are a global biopharma company with a special purpose – to unite science, technology and talent to get ahead of disease together – so we can positively impact the health of billions of people and deliver stronger, more sustainable shareholder returns – as an organisation where people can thrive. Getting ahead means preventing disease as well as treating it and we aim to impact the health of 2.5 billion people around the world in the next 10 years. Our success absolutely depends on our people. While getting ahead of disease together is about our ambition for patients and shareholders, it’s also about making GSK a place where people can thrive. We want GSK to be a place where people feel inspired, encouraged and challenged to be the best they can be. A place where they can be themselves – feeling welcome, valued and included. Where they can keep growing and look after their wellbeing. So, if you share our ambition, join us at this exciting moment in our journey to get Ahead Together. Find out more on our career site.